Sintilimab combined with bevacizumab in relapsed/persistent ovarian clear cell carcinoma (INOVA): an investigator-initiated, multicentre clinical trial-a study protocol of clinical trial.
Ruyuan LiXingyu LiuChunyan SongWei ZhangJiahao LiuXiaofei JiaoYang YuShaoqing ZengJianhua ChiYingjun ZhaoGuanchen MaYabing HuoMing LiZikun PengGuiling LiJie JiangQing-Lei GaoPublished in: BMJ open (2022)
NCT04735861; Clinicaltrials. gov.